Your browser doesn't support javascript.
loading
Inflammatory Bowel Disease Susceptibility Gene C1ORF106 Regulates Intestinal Epithelial Permeability.
Manzanillo, Paolo; Mouchess, Maria; Ota, Naruhisa; Dai, Bingbing; Ichikawa, Ryan; Wuster, Arthur; Haley, Benjamin; Alvarado, Gabriela; Kwon, Youngsu; Caothien, Roger; Roose-Girma, Meron; Warming, Soren; McKenzie, Brent S; Keir, Mary E; Scherl, Alexis; Ouyang, Wenjun; Yi, Tangsheng.
Affiliation
  • Manzanillo P; Department of Immunology Discovery, Genentech Inc., South San Francisco, CA 94080; yi.tangsheng@gene.com wouyang@amgen.com pmanzani@amgen.com.
  • Mouchess M; Department of Immunology Discovery, Genentech Inc., South San Francisco, CA 94080.
  • Ota N; Department of Immunology Discovery, Genentech Inc., South San Francisco, CA 94080.
  • Dai B; Department of Immunology Discovery, Genentech Inc., South San Francisco, CA 94080.
  • Ichikawa R; Department of Biomarker Discovery, Genentech Inc., South San Francisco, CA 94080.
  • Wuster A; Department of Human Genetics, Genentech Inc., South San Francisco, CA 94080.
  • Haley B; Department of Molecular Biology, Genentech Inc., South San Francisco, CA 94080.
  • Alvarado G; Department of Immunology Discovery, Genentech Inc., South San Francisco, CA 94080.
  • Kwon Y; Department of Translational Immunology, Genentech Inc., South San Francisco, CA 94080; and.
  • Caothien R; Department of Molecular Biology, Genentech Inc., South San Francisco, CA 94080.
  • Roose-Girma M; Department of Molecular Biology, Genentech Inc., South San Francisco, CA 94080.
  • Warming S; Department of Molecular Biology, Genentech Inc., South San Francisco, CA 94080.
  • McKenzie BS; Department of Translational Immunology, Genentech Inc., South San Francisco, CA 94080; and.
  • Keir ME; Department of Biomarker Discovery, Genentech Inc., South San Francisco, CA 94080.
  • Scherl A; Department of Pathology, Genentech Inc., South San Francisco, CA 94080.
  • Ouyang W; Department of Immunology Discovery, Genentech Inc., South San Francisco, CA 94080; yi.tangsheng@gene.com wouyang@amgen.com pmanzani@amgen.com.
  • Yi T; Department of Immunology Discovery, Genentech Inc., South San Francisco, CA 94080; yi.tangsheng@gene.com wouyang@amgen.com pmanzani@amgen.com.
Immunohorizons ; 2(5): 164-171, 2018 05 30.
Article in En | MEDLINE | ID: mdl-31022698
ABSTRACT
Intestinal epithelial cells form a physical barrier that is tightly regulated to control intestinal permeability. Proinflammatory cytokines, such as TNF-α, increase epithelial permeability through disruption of epithelial junctions. The regulation of the epithelial barrier in inflammatory gastrointestinal disease remains to be fully characterized. In this article, we show that the human inflammatory bowel disease genetic susceptibility gene C1ORF106 plays a key role in regulating gut epithelial permeability. C1ORF106 directly interacts with cytohesins to maintain functional epithelial cell junctions. C1orf106-deficient mice are hypersensitive to TNF-α-induced increase in epithelial permeability, and this is associated with increased diarrhea. This study identifies C1ORF106 as an epithelial cell junction protein, and the loss of C1ORF106 augments TNF-α-induced intestinal epithelial leakage and diarrhea that may play a critical role in the development of inflammatory bowel disease.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Carrier Proteins / Intestinal Mucosa Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Immunohorizons Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Carrier Proteins / Intestinal Mucosa Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Immunohorizons Year: 2018 Document type: Article